Senores Pharmaceuticals Releases FY26 Business Responsibility and Sustainability Report
Senores Pharmaceuticals Ltd 路 Others (Uncategorized) 路 03 Sept 2026, 10:38 pm
Senores Pharmaceuticals Releases FY26 Business Responsibility and Sustainability Report Senores Pharmaceuticals filed its FY26 BRSR for the year ending Mar'26. Standalone turnover reached INR 10,609 lakhs, alongside a net worth of INR 74,990 lakhs. Exports contributed 43.95% to total turnover. Highlighting strong operational compliance, the company reported zero regulatory penalties, product recalls, or data breaches during the year. Environmentally, Senores maintained its Zero Liquid Discharge status at the Mehsana plant and recorded total non-renewable energy consumption of 22.50 Tera Joules. Management confirmed full adherence to environmental and labor regulations with no pending stakeholder complaints.
Original exchange filing (PDF)
More announcements from Senores Pharmaceuticals Ltd
- We are pleased to announce that the manufacturing facility of our Subsidiary Company., Ratnatris Pharmaceuticals Private Limited has been awarded with the prestigious PIC/S GMP certification .... 路 18 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding transcript of earnings conference call held on October 29, 2026 路 05 Nov 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding audio recording of earnings conference call for quarter ended September 30, 2026 路 30 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible .... 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding submission of statement of deviation or variation in utilisation of funds of public issue for quarter ended on September 30, 2026 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Monitoring Agency report for the quarter ended September 30, 2026 路 29 Oct 2026
- We enclose herewith the Investor Presentation for Q2 & H1FY27 路 29 Oct 2026
- Senores Pharmaceuticals Limited has informed the exchange regarding Appointment of joint Statutory Auditor of the Company 路 29 Oct 2026
